COVID-19 is far from beaten. Vaccines may not be the ultimate panacea to haul us out of the pandemic crisis. In the future, will outbreaks of SARS-CoV-2, the virus that causes COVID-19, arrive in waves every winter? Might COVID-19 never go away? Experts at the University of California, Riverside, weigh…
The latest edition of the UC Davis Children’s Hospital Annual Report is now available. The publication covers2019-2020, an historic year that included the coronavirus and the separation of craniopagus twins.
UC Davis Comprehensive Cancer Center Director Primo “Lucky” Lara, Jr. helped author a clinical trial testing the best treatment for metastatic papillary kidney cancer. The promising results are published in The Lancet.
A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center helps identify which patients with prostate cancer will benefit most from the use of prostate-specific membrane antigen PET imaging, PSMA PET, a novel imaging technique that recently was approved by the U.S. Food and Drug Administration.
UC San Diego clinical trial suggests ivabradine may be effective in treating postural orthostatic tachycardia syndrome, a potential COVID-19 long-hauler symptom.
During Heart Failure Awareness Week (Feb. 16-19), nine UC Davis experts will discuss heart failure symptoms, prevention, treatment and more in interactive Facebook Live sessions.
Compared to sociobehavioral studies, biomedical studies typically require more time and visits, tend to be more quantitative, more in-person, and of greater risk
Health Media Contacts
Find the best contact for health-related media inquiries.
